首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Impact of Day-100 Response Post Autologous Stem Cell Transplantation (ASCT) in Waldenstrom Macroglobulinemia (WM)

【24h】

Impact of Day-100 Response Post Autologous Stem Cell Transplantation (ASCT) in Waldenstrom Macroglobulinemia (WM)

机译：自体干细胞移植（ASCT）后100天反应对Waldenstrom巨球蛋白血症（WM）的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2016年第1期|共1页
作者
Paludo Jonas; Gertz Morie; Ansell Stephen; Abeykoon Jithma P.; Dispenzieri Angela; Lacy Martha Q.; Kyle Robert; Buadi Francis; Dingli David; Hayman Suzanne; Gonsalves Wilson I.; Rajkumar S. Vincent; Kumar Shaji; Kapoor Prashant;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Impact of Day-100 Response Post Autologous Stem Cell Transplantation (ASCT) in Waldenstrom Macroglobulinemia (WM) [J] . Paludo Jonas, Gertz Morie, Ansell Stephen, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：自体干细胞移植（ASCT）后100天反应对Waldenstrom巨球蛋白血症（WM）的影响
2. Stem cell transplantation (SCT) for Waldenstrom's macroglobulinemia (WM). [J] . Anagnostopoulos A, Giralt S Bone marrow transplantation . 2002,第12期

机译：Waldenstrom巨球蛋白血症（WM）的干细胞移植（SCT）。
3. A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Recently Diagnosed Elderly Multiple Myeloma (MM) Patients. Safety and Response Results from the Prospective Phase II Trial (NCT01849783) [J] . Nadiminti Kalyan, Strouse Christopher, Vikas Praveen, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：单一的自体干细胞移植（ASCT）随后在最近诊断的老年骨髓瘤（MM）患者中进行两年的移植后治疗。潜在第二阶段试验的安全和响应结果（NCT01849783）
4. VAD CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR THE TREATMENT OF NEPHROTIC SYNDROME IN LIGHT CHAIN (AL) AMYLOIDOSIS [C] . J.B. Pen, S.O. Schonland, R.P. Linke, International Symposium on Amyloidosis . 2005

机译：VAD化疗，然后是自体干细胞移植（ASCT）用于在轻链（Al）淀粉样蛋白症中治疗肾病综合征
5. Posttraumatic stress disorder and sub-syndromal trauma symptoms in cancer patients treated with autologous hematopoietic stem cell transplant and standard dose chemotherapy. [D] . Gourvitz, Ross L. 2008

机译：自体造血干细胞移植和标准剂量化疗治疗的癌症患者的创伤后应激障碍和综合征下创伤症状。
6. The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd UK-MRA Myeloma XII trial): study protocol for a Phase III randomised controlled trial [O] . Alina Striha, A. John Ashcroft, Anna Hockaday, 2018

机译：ixazomib在复发性多发性骨髓瘤患者中作为挽救性自体干细胞移植（ASCT）的增强条件疗法以及ASCT后巩固和维持策略的作用（ACCoRd UK-MRA Myeloma XII试验）： III期随机对照试验
7. Targeting Myeloma Stem Cells with T Cells Armed with Anti-CD3 X Anti-CD20 Bispecific Antibody (CD20BI) Prior to ASCT Leads to Development of Anti-Myeloma Immune Responses Post Autologous Stem Cell Transplant That Can Be Boosted with Targeted T Cells [O] . Lawrence L.G., Archana T., Muneer A., 2012

机译：在ASCT之前，将具有抗CD3 X抗CD20双特异性抗体（CD20BI）的T细胞靶向骨髓瘤干细胞导致自体干细胞移植后抗骨髓瘤免疫反应的发展，可以用靶向T细胞增强

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号